The FDA has accepted the NDA for paltusotine for the treatment and long-term maintenance of acromegaly in adults.

Paltusotine was granted orphan drug designation for the treatment of acromegaly by the FDA in July 2020. Orphan drug ...

JMP Securities analyst Jonathan Wolleben has reiterated their bullish stance on CRNX stock, giving a Buy rating today.Pick the best stocks and ...

Pharmaceuticals announced the U.S. Food and Drug Administration, FDA, accepted its New Drug Application, NDA, for ...

Paltusotine was granted Orphan Drug Designation for the treatment of acromegaly by the FDA in July 2020. This designation is ...

Anti-seizure medications, which are also called anticonvulsants or anti-epileptic drugs (AEDs), are medications used to prevent seizures for people who have epilepsy. All AEDs are available only by ...